A Pilot Study to Explore Preliminary Safety, Tolerability and Efficacy of ORal IrON Supplementation With Ferric Maltol in Treating Iron Deficiency in Patients With Pulmonary Hypertension and Iron Deficiency Anemia
Phase of Trial: Phase III
Latest Information Update: 20 Jun 2019
Price : $35 *
At a glance
- Drugs Ferric maltol (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- Acronyms ORION-PH-1
- 17 Jun 2019 Planned End Date changed from 1 Jun 2019 to 1 Dec 2019.
- 17 Jun 2019 Planned primary completion date changed from 1 May 2019 to 1 Nov 2019.
- 31 Aug 2018 Biomarkers information updated